These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8302282)

  • 21. Cross-desensitization of receptors for peptide chemoattractants. Characterization of a new form of leukocyte regulation.
    Tomhave ED; Richardson RM; Didsbury JR; Menard L; Snyderman R; Ali H
    J Immunol; 1994 Oct; 153(7):3267-75. PubMed ID: 8089498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ligand-receptor dynamics and signal amplification in the neutrophil.
    Sklar LA; Bokoch GM; Swann WN; Comstock C; Smolen JE
    Int J Tissue React; 1987; 9(4):277-84. PubMed ID: 3114162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of isoprenoid metabolism in chemotactic peptide receptor-mediated G protein activation.
    McLeish KR; Lederer ED; Klein JB
    Biochem Biophys Res Commun; 1993 Dec; 197(2):763-70. PubMed ID: 8267613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations of F110 and C126 of the formyl peptide receptor interfere with G-protein coupling and chemotaxis.
    Jones BE; Miettinen HM; Jesaitis AJ; Mills JS
    J Periodontol; 2003 Apr; 74(4):475-84. PubMed ID: 12747452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative and qualitative differences in guanine nucleotide binding protein activation by formyl peptide and leukotriene B4 receptors.
    Schepers TM; Brier ME; McLeish KR
    J Biol Chem; 1992 Jan; 267(1):159-65. PubMed ID: 1309732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of receptor-G protein interactions in permeabilized cells.
    Wieland T; Liedel K; Kaldenberg-Stasch S; Meyer zu Heringdorf D; Schmidt M; Jakobs KH
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Apr; 351(4):329-36. PubMed ID: 7630424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Desensitization of formyl peptide receptors is abolished in calcium ionophore-primed neutrophils: an association of the ligand-receptor complex to the cytoskeleton is not required for a rapid termination of the NADPH-oxidase response.
    Liu L; Harbecke O; Elwing H; Follin P; Karlsson A; Dahlgren C
    J Immunol; 1998 Mar; 160(5):2463-8. PubMed ID: 9498791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetics and amplification in neutrophil activation and adaptation.
    Sklar LA; Omann GM
    Semin Cell Biol; 1990 Apr; 1(2):115-23. PubMed ID: 1966327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subtle differences between human and rabbit neutrophil receptors shown by the secretagogue activity of constrained formyl peptides.
    Dentino AR; Raj PA; De Nardin E
    Arch Biochem Biophys; 1997 Jan; 337(2):267-74. PubMed ID: 9016822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contribution of nucleoside diphosphokinase to guanine nucleotide regulation of agonist binding to formyl peptide receptors.
    Wieland T; Bremerich J; Gierschik P; Jakobs KH
    Eur J Pharmacol; 1991 Sep; 208(1):17-23. PubMed ID: 1657618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding of low affinity N-formyl peptide receptors to G protein. Characterization of a novel inactive receptor intermediate.
    Prossnitz ER; Schreiber RE; Bokoch GM; Ye RD
    J Biol Chem; 1995 May; 270(18):10686-94. PubMed ID: 7738006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemoattractant receptor-specific differences in G protein activation rates regulate effector enzyme and functional responses.
    Jacobs AA; Huber JL; Ward RA; Klein JB; McLeish KR
    J Leukoc Biol; 1995 Apr; 57(4):679-86. PubMed ID: 7722425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of C5a and formyl peptide receptor expression on human polymorphonuclear leukocytes.
    Van Epps DE; Simpson S; Bender JG; Chenoweth DE
    J Immunol; 1990 Feb; 144(3):1062-8. PubMed ID: 2295813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulatory interaction of N-formyl peptide chemoattractant receptors with the membrane skeleton in human neutrophils.
    Klotz KN; Krotec KL; Gripentrog J; Jesaitis AJ
    J Immunol; 1994 Jan; 152(2):801-10. PubMed ID: 8283053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of surrogate agonists for the human FPRL-1 receptor by autocrine selection in yeast.
    Klein C; Paul JI; Sauvé K; Schmidt MM; Arcangeli L; Ransom J; Trueheart J; Manfredi JP; Broach JR; Murphy AJ
    Nat Biotechnol; 1998 Dec; 16(13):1334-7. PubMed ID: 9853614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional molecular complexes of human N-formyl chemoattractant receptors and actin.
    Jesaitis AJ; Erickson RW; Klotz KN; Bommakanti RK; Siemsen DW
    J Immunol; 1993 Nov; 151(10):5653-65. PubMed ID: 8228254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-terminus urea-substituted chemotactic peptides: new potent agonists and antagonists toward the neutrophil fMLF receptor.
    Higgins JD; Bridger GJ; Derian CK; Beblavy MJ; Hernandez PE; Gaul FE; Abrams MJ; Pike MC; Solomon HF
    J Med Chem; 1996 Mar; 39(5):1013-5. PubMed ID: 8676333
    [No Abstract]   [Full Text] [Related]  

  • 38. Localization of ligand binding regions of the human formyl peptide receptor.
    Radel SJ; Genco RJ; De Nardin E
    Biochem Int; 1991 Nov; 25(4):745-53. PubMed ID: 1815508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neutrophil thrombospondin receptors are linked to GTP-binding proteins.
    Suchard SJ; Mansfield PJ
    J Cell Physiol; 1996 Jul; 168(1):217-27. PubMed ID: 8647918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guanine nucleotide regulatory proteins as transducers of receptor-stimulated neutrophil activation.
    Bokoch GM; Sklar LA; Smolen JE
    Int J Tissue React; 1987; 9(4):285-93. PubMed ID: 3114163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.